Home
Scholarly Works
Blind comparison of enoxaparin (a low molecular...
Conference

Blind comparison of enoxaparin (a low molecular weight heparin) with standard heparin in the treatment of unstable coronary artery disease ''the ESSENCE trial''

Authors

Cohen M; Turpie AGG; Demers C; Gurfinkel E; Fromell G; Langer A; Goodman S; Califf R; Fox K; Premmereur J

Pagination

pp. S1528-S1528

Publisher

SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN

Publication Date

June 1, 1997

Conference proceedings

THROMBOSIS AND HAEMOSTASIS

ISSN

0340-6245

Contact the Experts team